BMC Women's Health, 2020 Background A wide range of drugs have been studied for first trimester medical abortion. Studies evaluating different regimens, including combination mifepristone and misoprostol and misoprostol alone regimens, show varying results related to safety ...
Ferid A. Abubeker +3 more
doaj +2 more sources
Acceptability of misoprostol-only medication abortion dispensed by mail-order or retail pharmacy: a qualitative study based on in-depth interviews in the United States [PDF]
Sexual and Reproductive Health MattersThe WHO recommends two medication abortion regimens, either misoprostol used with mifepristone or misoprostol-only. Both regimens are recognised as safe and effective, but in the United States (US) most abortions are completed using mifepristone and ...
Dana M. Johnson +2 more
doaj +2 more sources
Evaluation of Low-dose and High-dose Intravaginal Misoprostol for Induction of Labour: A Randomised, Double-blinded, Single Centre Study [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Misoprostol is a synthetic prostaglandin E1 analogue widely used for cervical ripening and labour induction. However, optimal dose of misoprostol required to induce labour is still controversial.
Gowthami Mummalaneni +4 more
doaj +1 more source
Potency and acceptability of oral misoprostol compared with vaginal misoprostol prior to first trimester abortion [PDF]
New Indian Journal of OBGYN, 2020 Objectives: Present study was done to assess the effectiveness and acceptability of oral misoprostol compared with vaginal misoprostol for cervical priming before termination of first trimester pregnancy.
Varsha Kotwal
doaj +1 more source
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial. [PDF]
, 2020 BackgroundEarly pregnancy loss is a common event in the first trimester, occurring in 15%-20% of confirmed pregnancies. A common evidence-based medical regimen for early pregnancy loss uses misoprostol, a prostaglandin E1 analog, with a dosage of 800 μg,
Atrio, Jessica M +6 more
core +1 more source
Majalah Obstetri dan Ginekologi, 2023 HIGHLIGHTS • Oral misoprostol is more effective than vaginal misoprostol in cervical ripening as a part of induction of labor. • Oral misoprostol is as safe as vaginal misoprostol. ABSTRACT Objective: To compare Bishop score changes and labor
Maskasoni Maskasoni +1 more
doaj +1 more source
Comparative Study of Oral and Vaginal Misoprostol for Induction of Labour, Maternal and Foetal Outcome [PDF]
Journal of Clinical and Diagnostic Research, 2013 Background: Misoprostol is a new promising agent for cervical ripening and induction of labour .The ideal dose, route and frequency of administration of misoprostol are still under investigation.
Kambhampati Komala +4 more
doaj +1 more source
Journal of Family Medicine and Primary Care, 2023 Introduction: Misoprostol is widely used in the medical management of missed abortions. However, pretreatment with Mifepristone has shown to be effective but still not recommended to be used in missed abortions.
Nidhi Gupta +4 more
doaj +1 more source
Attenuation of ischemic liver injury by prostaglandin E
, 1998 Background: Prostaglandin has been reported to have protective effects against liver injury. Use of this agent in clinical settings, however, is limited because of drugrelated side effects.
Ishizaki, N +8 more
core +1 more source
Pharmaciana, 2014 In recent years, misoprostol that is a prostaglandin E1 analogue has been used in cervix ripening at pregnancy and labor induction. However, until now misoprostol dosage and administration route for induction are various.
Haafizah Dania +2 more
doaj +1 more source